NovaBay Pharmaceuticals held a special meeting where stockholders voted on three proposals, including the sale of eyecare products and liquidation of the company, but only the asset sale was approved, while liquidation did not receive enough votes (49% approval). The company plans to hold another meeting to seek approval for liquidation after selling most of its assets.